IRISH shoppers were left raging after New Look refused to honour vouchers – as Irish watchdog seeks clarification after “horrific” closing down sales. The fashion giant announced last ...
Zevra Therapeutics has inked a deal to sell its Food and Drug Administration priority-review voucher to an undisclosed buyer for gross proceeds of $150 million.
Genesys Worldwide is launching a national voucher sales platform designed to help radio stations generate additional revenue ...
The recent voucher sales by Zevra, PTC and Acadia are likely to be among the last in the childhood rare disease space. Back in September, the FDA said it would sunset its rare pediatric disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results